{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:22:52Z","timestamp":1793035372886,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10557-018-6804-z","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:21:46Z","timestamp":1530145306000},"page":"329-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1007","volume":"32","author":[{"given":"Su Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Yang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Gu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Yu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Keun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"6804_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"EC Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13\u201320.","journal-title":"Lancet"},{"key":"6804_CR2","doi-asserted-by":"crossref","unstructured":"Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807\u201318.","DOI":"10.1093\/eurheartj\/ehn220"},{"key":"6804_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87\u2013117.","journal-title":"Annu Rev Biomed Eng"},{"key":"6804_CR4","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","volume":"364","author":"KC Wollert","year":"2004","unstructured":"Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141\u20138.","journal-title":"Lancet"},{"key":"6804_CR6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa055706","volume":"355","author":"K Lunde","year":"2006","unstructured":"Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199\u2013209.","journal-title":"N Engl J Med"},{"key":"6804_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3346\/jkms.2014.29.1.23","volume":"29","author":"J-W Lee","year":"2014","unstructured":"Lee J-W, Lee S-H, Youn Y-J, Ahn M-S, Kim J-Y, Yoo B-S, et al. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci. 2014;29:23\u201331.","journal-title":"J Korean Med Sci"},{"key":"6804_CR8","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1056\/NEJMoa060186","volume":"355","author":"V Sch\u00e4chinger","year":"2006","unstructured":"Sch\u00e4chinger V, Erbs S, Els\u00e4sser A, Haberbosch W, Hambrecht R, H\u00f6lschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210\u201321.","journal-title":"N Engl J Med"},{"key":"6804_CR9","doi-asserted-by":"publisher","first-page":"975.e9","DOI":"10.1016\/j.ahj.2006.08.004","volume":"152","author":"J Meluz\u00edn","year":"2006","unstructured":"Meluz\u00edn J, Mayer J, Groch L, Janousek S, Horn\u00e1cek I, Hlinomaz O, et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J. 2006;152:975.e9\u201315.","journal-title":"Am Heart J"},{"issue":"7","key":"6804_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11936-014-0323-4","volume":"16","author":"BS Rahul Thakker","year":"2014","unstructured":"Rahul Thakker BS, Yang P. Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med. 2014;16(7):323\u201331.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"6804_CR11","doi-asserted-by":"crossref","unstructured":"Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction (review). Cochrane Library 2015; 9.","DOI":"10.1002\/14651858.CD006536.pub4"},{"key":"6804_CR12","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.jacc.2009.08.092","volume":"55","author":"A Armina\u2019n","year":"2010","unstructured":"Armina\u2019n A, Gandi\u2019 a C, Carc\u2019a-Verdugo JM, Lledo\u2019 E, Trigueros C, etal R-S\u2019A. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol. 2010;55:2244\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"EM Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44:671\u2013719.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","volume":"51","author":"EM Antman","year":"2008","unstructured":"Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51:210\u201347.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"FG Kushner","year":"2009","unstructured":"Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 focused updates: ACC\/AHA guidelines for the management of patients with ST elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC\/AHA\/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","volume":"367","author":"S Janssens","year":"2006","unstructured":"Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367:113\u201321.","journal-title":"Lancet"},{"key":"6804_CR17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","volume":"50","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Joint ESC\/ACCF\/AHA\/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR18","first-page":"2138","volume":"36","author":"G Germano","year":"1995","unstructured":"Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138\u201347.","journal-title":"J Nucl Med"},{"key":"6804_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"6804_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"6804_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.106.671545","volume":"116","author":"S Erbs","year":"2007","unstructured":"Erbs S, Linke A, Schachinger V, Assmus B, Thiele H, Diederich KW, et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation. 2007;116:366\u201374.","journal-title":"Circulation"},{"key":"6804_CR22","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jacc.2007.08.062","volume":"51","author":"WF Fearon","year":"2008","unstructured":"Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;51:560\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1172\/JCI200524283","volume":"115","author":"S Dimmeler","year":"2005","unstructured":"Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572\u201383.","journal-title":"J Clin Invest"},{"key":"6804_CR24","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1161\/CIRCULATIONAHA.105.546218","volume":"112","author":"CE Murry","year":"2005","unstructured":"Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112:3174\u201383.","journal-title":"Circulation"},{"key":"6804_CR25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","volume":"106","author":"BE Strauer","year":"2002","unstructured":"Strauer BE, Brehm M, Zeus T, K\u00f6stering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913\u20138.","journal-title":"Circulation"},{"key":"6804_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1055\/s-2001-16579-1","volume":"126","author":"BE Strauer","year":"2001","unstructured":"Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr. 2001;126:932\u20138.","journal-title":"Dtsch Med Wochenschr"},{"key":"6804_CR27","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1161\/CIRCULATIONAHA.108.827691","volume":"119","author":"G Lu","year":"2009","unstructured":"Lu G, Haider HK, Jiang S, Ashraf M. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation. 2009;119:2587\u201396.","journal-title":"Circulation"},{"key":"6804_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.jacc.2009.02.015","volume":"53","author":"T Kamota","year":"2009","unstructured":"Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Kubo M, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia\/reperfusion injury in the late phase. J Am Coll Cardiol. 2009;53:1814\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"6804_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","volume":"10","author":"SH Ranganath","year":"2012","unstructured":"Ranganath SH, Levy O, Inamdar MS, JMl K. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;10:244\u201354.","journal-title":"Cell Stem Cell"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-018-6804-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-018-6804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:18:19Z","timestamp":1561663099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-018-6804-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["6804"],"URL":"https:\/\/doi.org\/10.1007\/s10557-018-6804-z","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"28 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors have declared that no competing interests exit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}